Sodium nitroprusside - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for sodium nitroprusside and what is the scope of patent protection?

Sodium nitroprusside is the generic ingredient in four branded drugs marketed by Roche, Abbott, Abbvie, Hospira, Vpna, Abraxis Pharm, Amneal, Amphastar Pharms Inc, Avet Lifesciences, Baxter Hlthcare, Be Pharms, Caplin, Chartwell Rx, Cipla, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Micro Labs, Mylan Labs Ltd, Nexus, Norvium Bioscience, Sagent Pharms Inc, Slate Run Pharma, Somerset Theraps Llc, Sun Pharm, Teva Parenteral, Xiromed, and Exela Pharma, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for sodium nitroprusside. Sixteen suppliers are listed for this compound.

Sponsor

Phase

Egymedicalpedia

Early Phase 1

Tanta University

N/A

Kafrelsheikh University

N/A

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	SODIUM NITROPRUSSIDE	sodium nitroprusside	INJECTABLE;INJECTION	018581-001	Jul 28, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Avet Lifesciences	SODIUM NITROPRUSSIDE	sodium nitroprusside	INJECTABLE;INJECTION	208923-001	Nov 8, 2022		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abraxis Pharm	SODIUM NITROPRUSSIDE	sodium nitroprusside	INJECTABLE;INJECTION	070031-001	Jan 17, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Amphastar Pharms Inc	SODIUM NITROPRUSSIDE	sodium nitroprusside	INJECTABLE;INJECTION	209832-001	Dec 18, 2017		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbott	NITROPRESS	sodium nitroprusside	INJECTABLE;INJECTION	071555-001	Nov 16, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	4
Applicants:	28
NDAs:	29
Drug Master File Entries:	14
Finished Product Suppliers / Packagers:	16
Raw Ingredient (Bulk) Api Vendors:	42
Clinical Trials:	76
Patent Applications:	95
Drug Prices:	Drug price trends for sodium nitroprusside
What excipients (inactive ingredients) are in sodium nitroprusside?	sodium nitroprusside excipients list
DailyMed Link:	sodium nitroprusside at DailyMed

Drug Class	Vasodilator
Physiological Effect	Vasodilation